Eastern Cooperative Oncology Group
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://ecog-acrin.org
Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2003-11-05
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00005962
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸CCOP - Columbus, Columbus, Ohio, United States
Methylphenidate in Treating Patients With Melanoma
- Conditions
- FatigueUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2003-10-28
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 200
- Registration Number
- NCT00003266
- Locations
- 🇺🇸
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2003-10-22
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00025350
- Locations
- 🇺🇸
CCOP - Evanston, Evanston, Illinois, United States
🇺🇸CCOP - Kalamazoo, Kalamazoo, Michigan, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
- Conditions
- Liver CancerMetastatic Cancer
- Interventions
- First Posted Date
- 2003-10-09
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 50
- Registration Number
- NCT00003907
- Locations
- 🇺🇸
Rush-Copley Cancer Care Center, Aurora, Illinois, United States
🇺🇸Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia, United States
🇺🇸Borgess Medical Center, Kalamazoo, Michigan, United States
Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 4
- Registration Number
- NCT00070291
- Locations
- 🇺🇸
Hematology Oncology Associates of Illinois - Berwyn, Berwyn, Illinois, United States
🇺🇸Hematology Oncology Associates - Skokie, Skokie, Illinois, United States
🇺🇸Mercy Medical Center - Sioux City, Sioux City, Iowa, United States
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
- Conditions
- Hot FlashesBreast CancerMenopausal Symptoms
- First Posted Date
- 2003-09-17
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00026286
- Locations
- 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸CCOP - Northern New Jersey, Hackensack, New Jersey, United States
Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
- Conditions
- Metastatic Renal Cell CarcinomaRenal Cell Carcinoma With Sarcomatoid Features
- Interventions
- First Posted Date
- 2003-09-11
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 39
- Registration Number
- NCT00068393
- Locations
- 🇺🇸
Hematology and Oncology Associates, Chicago, Illinois, United States
🇺🇸Mercy Hospital and Medical Center, Chicago, Illinois, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
flt3L in Treating Patients With Acute Myeloid Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2003-09-03
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00006223
- Locations
- 🇺🇸
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
- Conditions
- Breast Cancer
- First Posted Date
- 2003-08-25
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00004125
- Locations
- 🇺🇸
State University of New York - Upstate Medical University, Syracuse, New York, United States
🇺🇸CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States
🇺🇸CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
- Conditions
- Colorectal CancerBladder CancerBreast CancerHead and Neck CancerTobacco Use DisorderUnspecified Adult Solid Tumor, Protocol SpecificLung CancerLymphomaProstate CancerTesticular Germ Cell Tumor
- Interventions
- Behavioral: Usual Care
- First Posted Date
- 2003-08-11
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 434
- Registration Number
- NCT00002520
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States